Mubasher TV
Contact Us Advertising   العربية

Memphis widens losses to EGP 15.4m in 10 months

Memphis widens losses to EGP 15.4m in 10 months
Photo Archive
Memphis Pharmaceutical
MPCI
1.10% 100.92 1.10

Cairo-Mubasher: Memphis Pharmaceutical posted EGP 15.4 million ($2 million) in losses for the 10-month period ended in April 2015, rising 1,238% compared with EGP 1.2 million ($156,000) a year earlier.

The company had posted losses of EGP 11.65 million ($1.5 million) for the nine-month period ended in December 2014, versus earnings of EGP 1 million ($130,600) in the same period a year ago.

Memphis operates with EGP 56.2 million in capital, divided into 5.6 million shares at a par value of EGP 10 each.